Range of movement change scores
| Week 1 Active (n=55), placebo (n=50) | Week 4 Active (n=54), placebo (n=51) | Week 12 Active (n=52), placebo (n=48) | ||||
|---|---|---|---|---|---|---|
| Outcome measure (max score) | Mean change (SD) | Difference in mean change between groups (95% CI) | Mean change (SD) | Difference in mean change between groups (95% CI) | Mean change (SD) | Difference in mean change between groups (95% CI) |
| *Significant at the 0.05 level. | ||||||
| Active abduction (180) | ||||||
| Active | 16.0 (19.1) | 10.46* (3.7 to 17.2) | 17.6 (20.2) | 13.7* (5.6 to 21.8) | 14.7 (21.9) | 9.6* (0.9 to 18.2) |
| Placebo | 5.6 (15.4) | 3.9 (21.6) | 5.1 (21.6) | |||
| Passive abduction (180) | ||||||
| Active | 20.3 (16.0) | 15.1* (8.6 to 21.6) | 20.8 (18.0) | 18.4* (10.0 to 26.8) | 16.0 (18.6) | 13.0* (5.0 to 21.0) |
| Placebo | 5.1 (17.5) | 2.4 (24.9) | 3.0 (21.6) | |||
| Active flexion (180) | ||||||
| Active | 8.6 (24.9) | −0.2 (−9.2 to 8.8) | 13.1 (27.6) | 6.8 (−3.0 to 16.7) | 9.9 (33.4) | 3.0 (−8.0 to 14.1) |
| Placebo | 8.8 (21.4) | 6.25 (22.8) | 6.8 (20.4) | |||
| Passive flexion (180) | ||||||
| Active | 9.9 (23.6) | 2.4 (−6.5 to 11.4) | 24.8 (70.1) | 19.1 (−1.50 to 39.6) | 9.8 (33.9) | 6.3 (−5.1 to 17.7) |
| Placebo | 7.4 (22.6) | 5.7 (25.0) | 3.5 (22.1) | |||
| Active external rotation (100) | ||||||
| Active | 5.1 (9.7) | 1.9 (−2.3 to 6.1) | 4.3 (9.2) | 1.4 (−2.4 to 5.3) | 3.7 (11.9) | 2.5 (−1.7 to 6.7) |
| Placebo | 3.2 (12.0) | 2.9 (10.8) | 1.2 (8.9) | |||
| Passive external rotation (100) | ||||||
| Active | 4.6 (8.9) | 3.5* (0.34 to 6.8) | 4.8 (10.5) | 2.9 (−0.9 to 6.7) | 4.5 (10.5) | 1.9 (−2.2 to 5.9) |
| Placebo | 1.0 (7.8) | 1.9 (9.3) | 2.6 (10.0) | |||
| Hand behind back | ||||||
| Active | 2.5 (3.4) | 2.0* (0.8 to 3.2) | 3.1 (3.7) | 2.7* (1.4 to 4.0) | 3.1 (3.7) | 2.7* (1.4 to 4.0) |
| Placebo | 0.5 (3.0) | 0.4 (2.9) | 0.4 (2.9) | |||